Crossmark

Chemotherapy accelerates immune-senescence and functional impairments of Vδ2pos T cells in elderly patients affected by liver metastatic colorectal cancer

Crossref DOI link: https://doi.org/10.1186/s40425-019-0825-4

Published Online: 2019-12-11

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bruni, Elena

Cazzetta, Valentina

Donadon, Matteo

Cimino, Matteo

Torzilli, Guido

Spata, Gianmarco

Leonardi, Gloria

Dieli, Francesco

Mikulak, Joanna

Mavilio, Domenico https://orcid.org/0000-0001-6147-0952
Funding

Funding for this research was provided by:

Ministero della Salute (PE-2016-02363915)

Associazione Angela Serra per la Ricerca sul Cancro (IG14687 and IG 21567)
License Information

Text and Data Mining valid from 2019-12-01
More Information

Article History

Received: 24 August 2019

Accepted: 21 November 2019

First Online: 11 December 2019

Ethics approval and consent to participate

: The collection of human samples for research purposes was ethically approved by the Institutional Review Board (IRB) of Humanitas Research Hospital (HRH) (Approval 168/18).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below